PD-L1 Testing and Assessment: Practical Considerations for Oncologist and Pathologist

被引：0
|
作者：
Pasricha, Sunil [1 ]
Durga, Garima [1 ,5 ]
Koyyala, Venkata Pradeep Babu [2 ]
Jajodia, Ankush [3 ]
Gupta, Gurudutt [1 ]
Mehta, Anurag [4 ]
机构：
[1] Rajiv Gandhi Canc Inst & Res Ctr, Dept Pathol, Delhi, India
[2] Assam Canc Care Fdn, Tezpur Canc Ctr, Dept Med Oncol, Gauhati, Assam, India
[3] McMaster Univ, Juravinski Hosp, Dept Radiol, Hamilton, ON, Canada
[4] Rajiv Gandhi Canc Inst & Res Ctr, Lab Serv & Res, Delhi, India
[5] Rajiv Gandhi Canc Inst & Res Ctr, Pathol Dept, Sect 5, Delhi 110085, India
来源：
INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY | 2024年 / 45卷 / 02期
关键词：
D O I：
10.1055/s-0042-1748797
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：157 / 162
页数：6
相关论文
共 50 条
  • [21] TAPping Into PD-L1 Testing Efficiency for Gastroesophageal Cancer
    Henick, Brian S.
    Moy, Ryan H.
    JCO PRECISION ONCOLOGY, 2024, 8
  • [22] The Role of PD-L1 Testing in Advanced Genitourinary Malignancies
    Hahn, Andrew W.
    Sirohi, Deepika
    Agarwal, Neeraj
    EUROPEAN UROLOGY FOCUS, 2020, 6 (01): : 11 - 13
  • [23] Reply to: Problems With the Recommendations for PD-L1 Biomarker Testing
    Torlakovic, Emina E.
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2020, 28 (07) : E65 - E67
  • [24] PD-L1 testing in urothelial carcinoma: are we there yet?
    van Leenders, Geert J. L. H.
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2019, 8 : S466 - S468
  • [25] Practical aspects of PD-L1 assessment in the treatment of urothelial carcinoma: Consensus of the uropathology group of the SEAP
    Lopez-Beltran, Antonio
    Gonzalez-Peramato, Pilar
    Sanz-Ortega, Julian
    Cuadra, Juan Daniel Prieto
    Trias, Isabel
    Barona, Rafael J. Luque
    Semidey, Maria Eugenia
    Maroto, Pablo
    Algaba, Ferran
    REVISTA ESPANOLA DE PATOLOGIA, 2023, 56 (04): : 261 - 270
  • [26] PD-L1 testing by immunohistochemistry in immuno-oncology
    Vranic, Semir
    Gatalica, Zoran
    BIOMOLECULES AND BIOMEDICINE, 2023, 23 (01): : 15 - 25
  • [27] A comparative study of PD-L1 diagnostic assays and the classification of patients as PD-L1 positive and PD-L1 negative
    Ratcliffe, Marianne J.
    Sharpe, Alan
    Midha, Anita
    Barker, Craig
    Scorer, Paul
    Walker, Jill
    CANCER RESEARCH, 2016, 76
  • [28] PD-L1 expression and PD-1/PD-L1 inhibitors in breast cancer
    Monneur, Audrey
    Goncalves, Anthony
    Bertucci, Francois
    BULLETIN DU CANCER, 2018, 105 (03) : 261 - 272
  • [29] Immunohistochemical assessment of the PD-1/PD-L1 axis in follicular lymphoma
    Szumera-Cieckiewicz, A.
    Sokol, K.
    Rymkiewicz, G.
    Jastrzebska, A.
    Paszkiewicz-Kozik, E.
    Kotarska, M.
    Walewski, J.
    Prochorec-Sobieszek, M.
    VIRCHOWS ARCHIV, 2018, 473 : S97 - S98
  • [30] Impact of Specimen Characteristics on PD-L1 Testing in Non-Small Cell Lung Cancer: Validation of the IASLC PD-L1 Testing Recommendations
    Gagne, Andreanne
    Wang, Emily
    Bastien, Nathalie
    Orain, Michele
    Desmeules, Patrice
    Page, Sylvain
    Trahan, Sylvain
    Couture, Christian
    Joubert, David
    Joubert, Philippe
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (12) : 2062 - 2070
12345